Cannula Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$178.3

Forecast, 2030 (US$M)

$294.6

CAGR, 2024 - 2030

7.4%

Report Coverage

Worldwide

Global cannula market, 2018-2030 (US$M)

Related Markets

Global cannula market highlights

The global cannula market generated a revenue of USD 178.3 million in 2023 and is expected to reach USD 294.6 million by 2030.
The market is expected to grow at a CAGR (2024 - 2030) of 7.4% by 2030.
In terms of segment, cardiac accounted for a revenue of USD 82.7 million in 2023.
Dermatology is the most lucrative product segment registering the fastest growth during the forecast period.
In terms of region, North America was the largest revenue generating market in 2023.
Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023	USD 178.3 million
Market revenue in 2030	USD 294.6 million
Growth rate	7.4% (CAGR from 2023 to 2030)
Largest segment	Cardiac
Fastest growing segment	Dermatology
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Cardiac, Dermatology, Nasal

Other key industry trends

In terms of revenue, the North America accounted for 41.0% of the global cannula market in 2023.
By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
By country, South Africa is the fastest growing regional market and is projected to reach USD 4.1 million by 2030.

Cardiac was the largest segment with a revenue share of 46.38% in 2023. Horizon Databook has segmented the Global cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.

The prevalence of lifestyle-associated diseases has been increasing rapidly in developing countries in the last few years. Thus, the demand for healthcare services for lifestyle-associated diseases, such as diabetes, cardiovascular diseases, cancer, is anticipated to increase, thereby driving market growth. Conditions such as diabetes mellitus, obesity, hypertension, and dyslipidemia are major risk factors for cardiovascular diseases.

In the UK, lifestyle-related diseases such as diabetes, cancer, and heart disease account for 90% of deaths each year. Cardiac arrhythmia, hypertension, ischemic conditions, sleep apnea, diabetes, hyperlipidemia, asthma, and chronic obstructive pulmonary disease are other chronic conditions that are reported globally. Such rise in cases of lifestyle-related disorders is anticipated to fuel market growth.

Key Regions: U.S. , UK , Japan , Brazil , UAE